MedPacto, Inc. (KOSDAQ:235980)
South Korea · Delayed Price · Currency is KRW 4,110.00
+45.00 (1.11%)
Aug 14, 2025, 3:30 PM KST
MedPacto Market Cap
MedPacto has a market cap or net worth of 140.87 billion as of August 15, 2025. Its market cap has decreased by -49.82% in one year.
Market Cap
140.87B
Enterprise Value
89.26B
Revenue
429.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
4,110.00
Market Cap Chart
Since December 19, 2019, MedPacto's market cap has decreased from 362.50B to 140.87B, a decrease of -61.14%. That is a compound annual growth rate of -15.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 140.87B | -7.33% |
| Dec 30, 2024 | 152.01B | -37.48% |
| Dec 28, 2023 | 243.12B | -48.17% |
| Dec 29, 2022 | 469.05B | -60.97% |
| Dec 30, 2021 | 1,201.91B | -49.78% |
| Dec 30, 2020 | 2,393.41B | 435.67% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.52T |
| Celltrion | 38.58T |
| ALTEOGEN | 23.35T |
| Yuhan | 8,561.74B |
| Peptron | 8,235.61B |
| SK Biopharmaceuticals | 7,878.31B |
| PharmaResearch | 7,106.52B |
| LigaChem Biosciences | 5,666.20B |